Global Needle-Free Drug Delivery Market Size, Analysis, Share, Trends, Business Growth and Forecast to 2024 |Says Report Hive Research

This article was originally published on this site

Sep 11, 2019 (Reporthive Research via COMTEX) — The Needle-Free Drug Delivery Market report separates the market by the top manufacturer, end users, and their application according to their respective data including market size & forecast, consumption, sales revenue, price, gross margin, supply and demand by region, and consumer profile. The report also analyze innovative business strategies, value added factors and business opportunities.

Needle free injection technology (NFIT)is an extremely broad concept which include a wide range of drug delivery systems that drive drugs through the skin using any of the forces as Lorentz, Shock waves, pressure by gas or electrophoresis which propels the drug through the skin, virtually nullifying the use of hypodermic needle. This technology is not only touted to be beneficial for the pharma industry but developing world too find it highly useful in mass immunization programmes, bypassing the chances of needle stick injuries and avoiding other complications including those arising due to multiple use of single needle.

Needle-based Injections continue to be the primary option for the delivering large molecule drugs which would break down in the gastrointestinal tract if consumed orally. Despite their common use, needles have several drawbacks including but not limited to needle stick injuries, patient non-compliance and needle phobia. Furthermore, needles can be a source of disease transmission, particularly when they are re-used and used incorrectly.

Request a Sample Copy Of This Report @

Key Companies

Endo Pharmaceuticals

Antares Pharma

Inovio Pharmaceuticals




Akra Dermojet

Consort Medical



Med Immune

Market Segment by Type, covers:

Jet injectors

Transdermal drug delivery systems

Market Segment by Applications, can be divided into:

Insulin delivery


Pain management

Regional Analysis For Needle-Free Drug Delivery Market:
United States
Southeast Asia
Central & South America

Top key questions answered in this report:
1. What are the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks)?
2. Which consumer segment accounted for the highest sales of Needle-Free Drug Delivery in 2019?
3. What are the business risks and factors concerning the market?
4. What are some of the most promising, high-growth opportunities for Needle-Free Drug Delivery market by applications, types and regions?
5. Which region offers the most lucrative opportunities for the market in 2019?
6. What Needle-Free Drug Delivery product types will be the most in-demand in the current year?
7. What sales channel will account for the largest sales?
8. What are the major challenges facing the Needle-Free Drug Delivery market?

Highlighted points of the global market research report:
It includes global market driving and restraining factors
It offers business profiles of various global investors
Analysis of micro and macro-economic factors impacting on the global market
View the Full Report @:
If you have any special requirements, please let us know and we will offer you the report as per your requirements.

Table of Contents
1 Market Overview
2 Manufacturers Profiles
3 Global Needle-Free Drug Delivery Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
4 Global Needle-Free Drug Delivery Market Analysis by Regions
10 Global Needle-Free Drug Delivery Market Segment by Type
11 Global Needle-Free Drug Delivery Market Segment by Application
12 Needle-Free Drug Delivery Market Forecast (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
Get Healthcare & Pharmaceutical Market Research updates covering key companies like : Pfizer Inc. PFE, +0.08%, Johnson & Johnson JNJ, +1.25%, Merck & Co., Inc. MRK, +1.51%, Bristol-Myers Squibb Co BMY, +1.40%, Medtronic PLC MDT, +1.07%, McKesson Corporation MCK, +3.98%, UnitedHealth Group Inc UNH, +0.75%, AmerisourceBergen Corp ABC, +2.22%, Abbott Laboratories ABT, +1.57%, Thermo Fisher Scientific Inc TMO, +1.88%, Cardinal Health Inc CAH, +1.94%
Report Hive Research
500, North Michigan Avenue,
Suite 6014
Chicago, IL – 60611
United States
Phone: +1 312-604-7084